The CHS, in collaboration with the Irish Haemophilia Society, is producing a new print publication, Key Developments in Novel Therapies for Bleeding Disorders. It is...
Montreal – April 3, 2026 – In the last few weeks, British Columbia and Ontario have approved access to HEMGENIX, gene therapy for hemophilia B....
By Sarah Ford The Canadian bleeding disorders community mourns the passing of longtime volunteer and advocate Marion Stolte, whose dedication and leadership helped improve the...
The CHS has awarded three fellowships to attend the WFH World Congress in Malaysia this upcoming April. CLICK HERE to meet the 2026 Karttik Shah Fellowship...
The CHS has produced a new podcast series entitled NOVEL THERAPIES FOR BLEEDING DISORDERS. The series explores therapies that are potentially coming to the Canadian...